Transcripts Orexo AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 06:59:33 2024-04-30 am EDT			5-day change	1st Jan Change
16.9 ^SEK	+2.67%		+7.10%	+9.31%

Apr. 17	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT
Apr. 17	Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	CI

Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024	Feb. 08
Transcript : Orexo AB, Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Transcript : Orexo AB, Q2 2023 Earnings Call, Jul 18, 2023	23-07-18
Transcript : Orexo AB, Q1 2023 Earnings Call, Apr 27, 2023	23-04-27
Transcript : Orexo AB, 2022 Earnings Call, Jan 26, 2023	23-01-26
Transcript : Orexo AB, Q3 2022 Earnings Call, Nov 03, 2022	22-11-03
Transcript : Orexo AB, Q2 2022 Earnings Call, Jul 14, 2022	22-07-14
Transcript : Orexo AB, Q1 2022 Earnings Call, Apr 28, 2022	22-04-28
Transcript : Orexo AB, Q4 2021 Earnings Call, Jan 27, 2022	22-01-27
Transcript : Orexo AB, Q3 2021 Earnings Call, Nov 03, 2021	21-11-03
Transcript : Orexo AB, Q2 2021 Earnings Call, Jul 15, 2021	21-07-15
Transcript : Orexo AB, Q1 2021 Earnings Call, Apr 29, 2021	21-04-29
Transcript : Orexo AB, Q4 2020 Earnings Call, Jan 28, 2021	21-01-28
Transcript : Orexo AB, Nine Months 2020 Earnings Call, Nov 04, 2020	20-11-04
Orexo AB Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020	20-11-04	CI
Transcript : Orexo AB - Special Call	20-10-01
Transcript : Orexo AB, Q2 2020 Earnings Call, Jul 16, 2020	20-07-16
Transcript : Orexo AB - Special Call	20-07-02
Transcript : Orexo AB, Q1 2020 Earnings Call, Apr 28, 2020	20-04-28
Orexo AB Provides Earnings Guidance for the Year 2020	20-04-28	CI

No results for this search